Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live Attenuated VZV Vaccine for Herpes Zoster Prevention in Adults 40+
NCT03314103Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Oct 2017
- Primary completion
- Jan 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of zoster vaccine live in herpes zoster (HZ), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Oct 2017; status: completed.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03314103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03314103.